X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.760
+0.010 (0.27%)
At close: Jan 22, 2026, 4:00 PM EST
3.750
-0.010 (-0.27%)
After-hours: Jan 22, 2026, 5:07 PM EST
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 143 employees as of December 31, 2024. The number of employees increased by 50 or 53.76% compared to the previous year.
Employees
143
Change (1Y)
50
Growth (1Y)
53.76%
Revenue / Employee
$237,615
Profits / Employee
-$665,000
Market Cap
328.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 143 | 50 | 53.76% |
| Dec 31, 2023 | 93 | 23 | 32.86% |
| Dec 31, 2022 | 70 | -13 | -15.66% |
| Dec 31, 2021 | 83 | 11 | 15.28% |
| Dec 31, 2020 | 72 | 14 | 24.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AC Immune | 172 |
| Puma Biotechnology | 172 |
| Neumora Therapeutics | 110 |
| Aura Biosciences | 109 |
| Immuneering | 66 |
| Tectonic Therapeutic | 51 |
| Candel Therapeutics | 38 |
| Protara Therapeutics | 33 |
XFOR News
- 7 weeks ago - X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia - Seeking Alpha
- 2 months ago - X4 Pharmaceuticals to Participate in Guggenheim's Second Annual Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million - GlobeNewsWire
- 3 months ago - X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering - GlobeNewsWire
- 3 months ago - X4 Pharmaceuticals Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 4 months ago - X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation - GlobeNewsWire
- 5 months ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire